Chronic overexpression of the oncogenic form of Ras is a potent inhibitor of skeletal myogenesis. However, the intracellular signaling pathways that mediate the repressive actions of Ras on myogenic dierentiation have yet to be identi®ed. We examined the role of Rafmediated signaling as a modulator of avian myogenesis. Raf overexpression elicited pronounced eects on both myoblasts and mature myocytes. Most notably, the embryonic chick myoblasts overexpressing a constitutively active form of Raf (RCAS-Raf CAAX or RCASRaf BXB) fail to form the large multinucleated myo®bers characteristic of myogenic cultures. While residual myo®bers were apparent in the RCAS-Raf BXB and RCAS-Raf CAAX infected cultures, these ®bers had an atrophic phenotype. The altered morphology is not a result of reinitiation of the myonuclei cell cycle nor is it due to apoptosis. Furthermore, the mononucleated myoblasts misexpressing Raf BXB are dierentiationdefective due to overt MAPK activity. Supplementation of the culture media with the MAPK kinase (MEK) inhibitor, PD98059, caused a reversal of the phenotype and allowed the formation of multinucleated myo®bers at levels comparable to controls. Our results indicate that the Raf/MEK/MAPK axis is intact in chick myoblasts and that persistent activation of this signaling cascade is inhibitory to myogenesis.
Introduction
The formation of skeletal muscle represents a coordinated series of events whereby a mononucleated myoblast terminally dierentiates into the multinucleated myo®bers, which are responsible for the synthesis of the contractile proteins. Inherent to this multistep phenotypic transformation is the activation of a tissue-restricted class of basic helix ± loop ± helix (bHLH) transcription factors, collectively referred to as the myogenic regulatory factors (MRFs; Ludolph and Konieczny, 1995) . While each of the transcription factors, myf-5, MyoD, myogenin, MRF4, can activate the myogenic program when ectopically expressed in non-muscle cells in vitro, their spatio-temporal expression during development regulates discrete phases of myogenesis in vivo (Molkentin and Olson, 1996) . The ability of the MRFs to confer the dierentiated phenotype is acutely aected by the external environment of the cell such that the ultimate decision of a myoblast to proliferate or dierentiate is determined by the presence and or absence of speci®c growth factors (Lassar and Munsterberg, 1996) . In vitro, high serum concentrations and members of the ®broblast growth factor (FGF) and transforming growth factor (TGF-b) superfamilies, strongly antagonize terminal differentiation (Florini et al., 1991; Olson, 1992) . The mechanism whereby negative regulation is imposed by these factors is largely unknown; however, it likely involves reversible phosphorylation events. The MRFs contain consensus phosphorylation sites for numerous kinases and, as such, are strong candidates for phosphoregulation. Indeed, FGF2 generated signaling cascades lead to the phosphorylation of a conserved threonine located with the DNA binding domain of myogenin (Li et al., 1992) . Modi®cation of this site prevents the MRF from interacting with DNA and initiating muscle gene transcription. However, the corresponding threonine within the basic region of MyoD and MRF4 fails to become hyperphosphorylated in response to FGF2 stimulus and the MRF-containing heterodimers maintain their DNA binding capacity (Hardy et al., 1993) . The discrepancies between FGF2-induced actions infer that myogenic repression is determined by multiple factors, which may include phosphorylation status of the MRFs and their ability to participate in protein : protein interactions.
Deregulated activity of intracellular kinases and transcription factors is often associated with cellular transformation and tumorigenesis. As such, it is not surprising that misexpression of the activated forms of many oncogenes can lead to a dramatic repression of myogenesis (Alema and Tato, 1994) . Multiple reports exist documenting the profound inhibitory eects of overexpression of oncogenic Ras on skeletal myogenesis (Olson et al., 1987; Konieczny et al., 1989; Lassar et al., 1989; Vaidya et al., 1991) . Ras, a membrane localized GTPase, plays a pivot role in the initiation of multiple intracellular signaling cascades, including those crucial for cellular proliferation and transformation (White et al., 1995) . While the mechanism by which activated Ras inhibits myogenesis is largely unknown, repression can not be attributed solely to altered MRF function. Indeed, both MyoD and MRF4 retain their innate transcriptional and DNA binding functions in myoblasts constitutively expressing an activated allele of ras (Kong et al., 1995) . Furthermore, Ras mutants that independently activate the linear Raf/MEK/MAPK axis or the Rac/Rho pathway both inhibit MyoD-mediated myogenesis (Ramocki et al., 1997) . Interestingly, the key signaling intermediates of these pathways, MEK, Rac and Rho, are not responsible for mediating the repressive actions of the Ras mutants (Ramocki et al., 1997) . Rather, these downstream eectors may play a positive role during myogenesis (Gredinger et al., 1998; Takano et al., 1998) . Overexpression of activated MEK enhances the transcriptional activity of MyoD and allows for the formation of myo®bers in the presence of serum mitogens (Gredinger et al., 1998) . And, misexpression of a dominant inhibitory form of Rho prevents C2C12 myo®ber formation possibly through a mechanism that involves downregulation of myogenin and MRF4 expression (Takano et al., 1998) . Because Ras signaling is inhibitory to myogenesis but MEK may be stimulatory, we chose to examine the role of Raf, the kinase responsible for connecting upstream Ras to MEK. Our results demonstrate that overexpression of activated Raf, similar to Ras, inhibits myogenesis. However, unlike activated Ras, the repressive actions of Raf are a consequence of elevated MAPK activity.
Results

Augmented Raf kinase levels are produced by retroviral transduction
One of the most exhaustively studied intracellular signaling pathway activated by Ras is the Raf/MEK/ MAPK cascade. Translocation of Raf to the plasma membrane places the kinase in close proximity to Ras allowing for its activation (Avruch et al., 1994) . In turn, Raf phosphorylates MEK enabling it to phosphorylate MAPK, a kinase essential for the regulation of multiple transcription factors (Denhardt, 1996) . To examine the eects of Raf kinase on myogenesis, we chose to overexpress two constitutively active forms of the kinase, Raf CAAX, a membrane-localized form and Raf BXB, a truncated form of Raf lacking the regulatory subunit (Bruder, et al., 1992 ). An additional mutant, Raf BXB301, encoding for a kinase-defective form of Raf BXB, was also tested (Bruder et al., 1992) . We chose to overexpress the Raf cDNAs using a replicationcompetent retroviral system (RCAS) with minor modi®cations (Petropoulos and Hughes, 1991) . Due to variations in the translation eciency of the multiple RCAS transcripts, the protein of interest can often be produced at suboptimal levels. As a means of improving the eciency of protein expression and detection, an internal ribsomal entry site (IRES) sequence and epitope tag (myc) were inserted upstream of the amino terminus of the Raf cDNAs. The bene®ts of this modi®cation were determined by examination of both the levels and extent of protein expression in transduced primary myoblast cultures. Brie¯y, myoblasts were isolated from the hindlimbs of ED10 avian embryos and transfected with proviral DNA for RCAS, RCAS-Raf CAAX, RCAS-Raf BXB and RCAS-Raf BXB301. After 4 days in culture, plates of the infected cells were lysed and analysed for relative levels of Raf protein content. Western analysis of equal amounts of total cellular protein revealed a These results indicate that abundant levels of Raf protein expression can be attained using the retroviral mis-expression system. Moreover, the eects of Raf overexpression on cellular morphology are readily apparent in the myogenic cultures. During the ®rst 2 days in culture, control myoblasts are found as proliferating mononuclear cells with a somewhat¯at appearance ( Figure 1B a) . After 3 days in culture, the cells begin to exit the cell cycle and form myo®bers. Typical myo®bers found after 4 days are quite large with upwards of 50 nuclei contained within their structural boundaries ( Figure 1B b) . In contrast, the myogenic cultures infected with RCAS-Raf CAAX and RCAS-Raf BXB demonstrated striking eects on the overall morphology of both the mononucleated and multinucleated cells ( Figure 1B c and d ). Vast majorities of the cells expressing Raf CAAX or Raf BXB are found as mononuclear, spindle-shaped cells of a light refractile nature when viewed under phase contrast microscopy. In addition, the myogenic cells overexpressing activated Raf alleles are smaller with an apparent reduced cytoplasmic volume than either RCAS or RCAS-Raf BXB301 transduced cells. While the morphology of RCAS-Raf CAAX and RCAS-Raf BXB transduced myoblasts are similar in many respects, the two activated alleles also direct distinctly dierent eects on the cytoskeleton. For example, Raf CAAX expressing myogenic cells often possess long lamellipodia-like structures protruding from the apical ends that are not found in Raf BXB expressing cells. Cytochemical staining of these cells with phalloidinTexas Red to visually appraise the actin cytoskeleton did not reveal an induction of stress ®bers, membrane ruing or focal adhesion contact by Raf BXB or Raf CAAX (data not shown). This result implies that the altered morphology does not involve Raf induction of Rac and Rho signaling pathways. Furthermore, the ability of activated Raf kinases to disrupt the normal dierentiated phenotype is a result of kinase activity as myogenic cultures transduced with Raf BXB301 are morphologically no dierent than controls ( Figure 1B e). Completion of our preliminary expression studies indicates that the degree of retroviral infection is extensive after the 4 day culture period resulting in the production of Raf proteins of the correct size and cellular localization. Moreover, overexpression of constitutively active Raf disrupts normal myoblast morphology and myocyte formation.
Activated Raf inhibits avian myogenesis
Our observation of an acutely altered morphology of the myogenic cells in response to activated Raf overexpression was a strong indication that the dierentiation program of these cells also was inhibited. To determine if the myoblasts were capable of initiating the muscle gene program but were fusiondefective, ED10 muscle cells were isolated and infected as described. After 4 days, the cells were ®xed and immunostained for myosin heavy chain (MyHC) expression. As seen previously, avian myoblasts infected with RCAS readily dierentiate into large, multinucleated myo®bers capable of synthesizing the contractile protein myosin (Figure 2 ). Along these same lines, myogenic cultures infected with RCAS-Raf BXB301 contained MyHC immunoreactive myo®bers indicating that disruption of Raf signaling pathways is not detrimental to myogenesis (Figure 2 ). However, in both the RCAS-Raf CAAX and -Raf BXB cultures, a dramatic reduction in the total number of myo®bers was found. In addition, the mononucleated cells failed to express the structural protein suggesting that the entire dierentiation program is inhibited and not simply the ability to fuse (Figure 2 ). Of the residual MyHC-expressing ®bers found in the Raf CAAX and Raf BXB overexpressing cultures, severe morphological alterations were noted. The myo®bers were short and spindle-shaped with an unenven distribution of myosin expression. In addition, the nuclei contained within the ®ber remnants are often found as a centrally located aggregate. The reduction in myocyte formation is not a consequence of cell death as DAPI staining revealed no signi®cant dierences in total number of nuclei ( Figure  2 ). These myocytes represent a very small fraction of the population and probably arise due to the fusion of committed cells present in the initial myoblast isolation. Our results contend that not only does chronic Raf activity inhibit dierentiation, it also appears to be deleterious to sustained activation of the myogenic program.
Myocyte degeneration does not involve reinduction of the cell cycle
Disruption of the intact dierentiation program and subsequent ®ber degeneration by activated Raf was quite unexpected. Myo®ber degeneration and disorganization of the cytoskeleton resulted in the formation of structures reminiscent of the foci found in cultures of transformed ®broblasts. Because chronic Raf activity can cause transformation in some cell types and the kinase also participates in cell proliferation, we reasoned that the RCAS-Raf CAAX and RCASRaf BXB infected myocytes may have reentered the cell cycle. Reinitiation of DNA synthesis would be unsuited with maintenance of the dierentiation program. To examine this issue, cultures of myoblasts were isolated and infected with RCAS, RCAS-Raf CAAX and RCAS-Raf BXB, as described previously. Twenty minutes prior to culture termination, the cells were pulsed with the thymidine analog, bromodeoxyuridine (BrdU). Subsequently, the cultures were ®xed and immunostained for BrdU incorporation and MyHC expression. As shown in Figure 3 , control RCAS infected cells form large, multinucleated MyHC expressing myo®bers. And, as expected, the nuclei contained within the RCAS myocytes were postmitotic as determined by their inability to incorporate BrdU. Cells immunostained for BrdU can be found adjacent to the myo®ber indicating that a portion of the myoblasts are still undergoing replication. For technical reasons, we were unable to show the corresponding DAPI stain for total nuclei. Similar to previous results, the residual myocytes found in the RCAS-Raf CAAX and RCAS-Raf BXB transduced cultures are morphologically atypical. The myocytes are dramatically smaller than control myocytes and demonstrate long MyHC-immunostained protrusions from the central myocyte body. Moreover, in both Raf CAAX and Raf BXB myocytes, an uneven distribution of myosin is found presenting a weblike pattern of MyHC immunostaining. However, the inability of these myo®bers to maintain MyHC expression and sarcomere organization is not a result of endoreplication as at no time were we able to ®nd BrdU positive nuclei within the con®nes of a MyHC positive cell. We conclude that the severely disrupted morphology of the existing myocytes is not due to reinitiation of the cell cycle. Moreover, the inability of the remaining myoblasts to dierentiate in the RCASRaf BXB and RCAS-Raf CAAX cultures is not due to elevated proliferation rates. The percentage of total nuclei incorporating BrdU is 33, 20 and 24% for RCAS, RCAS-Raf CAAX and RCAS-Raf BXB transduced cultures, respectively. While the labeling index for the Raf BXB and Raf CAAX expressing cells is lower, these values are not signi®cantly dierent from control (P50.05). Results of these pulse-labeling experiments infer that the morphological anomalies between activated Raf-expressing myo®bers and control myo®bers are not a result of reinitiation of the cell cycle.
Activated Raf does not promote apoptosis in avian myocytes
Raf kinase is one of several substrates for Ras, a membrane localized GTPase that mediates multiple receptor tyrosine kinase functions (Joneson and BarSagi, 1997) . Associated with the forced expression of Ras is the induction of apoptosis (Downward, 1998) . The mechanism by which Ras causes apoptotic death is unclear but may involve Raf activation (Kauman-Zeh et al., 1997) . With this premise in mind, we examined the altered morphology of the RCAS-Raf BXB and RCAS-Raf CAAX myo®bers as a consequence of apoptosis. Cultures of myoblasts were established, infected and cultured as described previously. At the end of the culture period, genomic DNA was isolated from RCAS, RCAS-Raf BXB and RCAS-Raf CAAX cells and analysed for the presence of DNA fragmentation. Electrophoretic separation of the genomic DNA isolates through agarose gels demonstrated that the DNA present in control RCAS cultures was represented by a high molecular weight band ( Figure 4A) . Furthermore, the genomic DNA isolated from either the Raf BXB or Raf CAAX overexpressing cells did not dier from control. Low molecular weight DNA fragments, a characteristic of apoptotic DNA, were not Figure 4A ). The lack of apoptotic activity was con®rmed by TUNEL assay (ApoAlert DNA Fragmentation Assay, Clontech). RCAS, RCAS-Raf BXB and RCAS-Raf CAAX transduced cultures were ®xed with paraformaldehyde and examined for their ability to incorporate¯uorescent-tagged nucleotides into fragmented DNA. As shown in Figure 4B , the transduced cultures do not demonstrate apoptotic nuclei by TUNEL assay. C3H10T1/2 ®broblasts used as a positive control for the assay readily incorporate the labeled nucleotide. Again, it is interesting to note that the size and shape of the nuclei in both the RCASRaf CAAX and RCAS-Raf BXB groups dier than the control RCAS transduced cells. The nuclei within the Raf expressing groups are smaller and rounder than their control counterparts. However, the absence of genomic DNA fragmentation argues that chronic Raf kinase activity does not give rise to programmed cell death in avian myogenic cells nor contribute to disrupted myo®ber morphology.
Activated Raf inhibits myogenesis through MEK-dependent and -independent pathways
Raf kinase participates in the linear Raf/MEK/MAPK signaling cassette by phosphorylating MEK, which phosphorylates MAPK. Activated or phosphorylated MAPK translocates to the nucleus to modify transcription factors, thus, serving to regulate cellular responses. We reasoned that if MAPK is responsible for mediating the inhibitory eects of Raf kinase, then removal of MAPK activity should allow for myo®ber formation. Primary cultures of chick myoblasts were cultured and infected as described previously. During the ®nal 48 h of culture, a chemical inhibitor speci®c to MEK (PD98059; New England Biolabs) was included in the media. The concentration of the inhibitor (50 mM) was shown in pilot studies to be sucient to eliminate MAPK activity (data not shown). At the end of the culture period, the cells were analysed for MyHC expression by Western blot. As shown in Figure 5A , both RCAS and RCAS-Raf BXB301 transduced cultures synthesize MyHC, a marker of terminal dierentiation, in media supplemented with vehicle only (DMSO). Moreover, neither RCAS-Raf CAAX nor RCAS-Raf BXB infected cultures produce detectable amounts of MyHC protein in the absence of PD98059. Western analysis of lysates prepared from cells cultured in the presence of the MEK inhibitor are shown in the lower panel of Figure 5A . Control cells treated with PD98059 continued to synthesize MyHC, suggesting that MEK is not required for differentiation. Indeed, MEK activity may be inhibitory to myogenesis as treatment of RCAS-Raf BXB transduced cultures with PD98059 removed the block to MyHC expression ( Figure 5A ). Unexpectedly, a similar ®nding was not observed in RCAS-Raf CAAX infected cultures. Myogenic cells overexpressing Raf CAAX remained unresponsive to the eects of PD98059 ( Figure 5A ). Lysates prepared from these cultures contained very low levels of MyHC protein that are only apparent after prolonged chemiluminescent detection. To ensure that morphological differentiation was aected in an analogous manner, parallel plates of cells were treated as described above and immunostained for MyHC expression. Similar to the Western analysis, supplementation of the culture medium with the MEK inhibitor produced no observable eects on the ability of control cells to form MyHC immunoreactive ®bers [RCAS (7) vs RCAS (+)]. Mock treated (DMSO) myocytes over- Figure 3 Altered myo®ber morphology is not a consequence of reinitiation of myonuclei cell cycle. Chick myoblasts were infected and cultured as described. Twenty minutes prior to ®xation, the cells were pulsed with BrdU. Cultures were immunostained with anti-BrdU and goat anti-mouse Texas Red followed by incubation with anti-MyHC and goat anti-mouse-FITC. RCAS, RCAS-Raf CAAX and RCAS-Raf BXB infected cultures contain myo®bers (green) which are post-mitotic. Mononucleated, mitotically active nuclei (red) are located outside of the myocyte boundaries A B Figure 4 Raf-mediated myo®ber degeneration is not due to apoptosis. Cultures of chick myoblasts were infected with RCAS, RCAS-Raf CAAX and RCAS-Raf BXB (A) After 4 days, genomic DNA was isolated and electrophoresed through 1.2% TAEagarose gels. Ethidium bromide staining demonstrates that only high molecular weight DNA is present in the infected cells. Apoptotic fragments are not found in the 200 ± 1000 base pair range. DNA molecular weight markers are lambda digested with HindIII (HM) and phiX174 digested with HaeIII (LM). Base pair sizes of the DNA fragments are shown. (B) Parallel plates of infected myocytes were ®xed with 4% paraformaldehyde and analysed by TUNEL assay. C3H10T1/2 ®broblasts were used as a positive control for the assay. All cells were counterstained with DAPI for the visualization of nuclei. Images are representative ®elds photographed under 406 optics expressing Raf BXB [RCAS-Raf BXB (7) failed to dierentiate but, regained their ability to form MyHCexpressing ®bers following treatment with 50 mM PD98059 [RCAS-Raf BXB (+)]. In contrast, myocytes overexpressing Raf CAAX remained refractile to the eects of PD98059 [RCAS-Raf CAAX (7) vs RCAS-Raf CAAX (+)]. The infrequent myo®bers present in cultures treated with MEK inhibitor [RCAS-Raf CAAX (7)] remained morphologically no dierent than control DMSO-treated cells [RCASRaf CAAX (+)]. Our results provide evidence that Raf CAAX inhibits myogenesis through a MEK-independent mechanism, while Raf BXB serves to repress myogenesis through a MEK-dependent signaling path.
Activated Raf inhibits myogenesis through elevated MAPK activity
The ability of RCAS-Raf BXB to inhibit myogenesis in a MEK-dependent fashion would suggest that the linear Raf/MEK/MAPK axis is intact. Along these same lines, our data would indicate that Raf CAAX inhibits myogenesis through an alternate pahway that does not culminate in MAPK activation. To examine the role of downstream MAPK as a mediator of myogenic repression, we analysed the levels of activated MAPK in cultures overexpressing the activated Raf isoforms. Brie¯y, ED10 myoblast cultures were established and infected as described. During the ®nal 48 h of culture, parallel plates of RCAS, RCAS-Raf CAAX and RCASRaf BXB infected cells were treated with 50 mM PD98059. Subsequently, total cell lysates were prepared and analysed by Western blot for total and active MAPK expression. As shown in the lower panel of Figure 6A , no dierences were found in the total amounts of MAPK protein between the various groups. A single immunoreactive band of 44 kDa was present following chemiluminescent detection. Furthermore, extracts prepared from both RCAS and RCAS-Raf BXB301 infected cells demonstrate a low to nondetectable level of active, phosphoMAPK ( Figure 6A, upper panel) . As predicted, overexpression of Raf-BXB produced a strong immunoreactive band for active MAPK. Somewhat surprisingly, cell lysates prepared from RCAS-Raf CAAX also induced activation of MAPK as determined by the presence of an immunoreactive phosphoMAPK protein band. These results indicate that both of the constitutively active Raf proteins can induce downstream MAPK activity. Analysis of cell extracts prepared from cells treated with the MEK inhibitor, PD98059, yielded some very interesting information. As expected, neither Figure 6 Raf BXB inhibits myogenesis through elevated MAPK activity. Cultures of RCAS, RCAS-Raf CAAX and RCAS-Raf BXB myoblasts were cultured for 48 h in the absence (A) or presence (B) of 50 mM PD98059. Cell lysates were prepared and analysed by Western blot for total MAPK (lower panels) and phosphorylated MAPK (upper panels). Immunoreactive bands were visualized by chemiluminescence RCAS nor RCAS-Raf BXB301 transduced cultures contained detectable amounts of phosphoMAPK following PD98059 treatment ( Figure 6B ). In a similar fashion, myogenic cells infected with RCAS-Raf BXB were responsive to the eects of PD98059 as demonstrated by a reduction in the amount of phosphoMAPK ( Figure 6B, upper panel) . However, treatment of RCASRaf CAAX transduced myoblasts had no eect on the activation of MAPK ( Figure 6B, upper panel) . The relative amounts of phosphoMAPK in lysates prepared from Raf CAAX-expressing cells did not change as a function of PD98059 supplementation. These results allow us to conclude that both RCAS-Raf CAAX and RCAS-Raf BXB inhibit myogenesis through induction of MAPK activity. However, the two activated forms of Raf direct myogenic repression through dierent signaling mechanisms. Raf BXB participates in the linear Raf/MEK/MAPK axis while Raf CAAX works through a MEK-independent mechanism.
Discussion
Historically, MAPK has been regarded as a key regulator of cell proliferation (Joneson and Bar-Sagi, 1997) . However, from work with PC12 neuronal cells, it is apparent that MAPK activity can also promote cellular dierentiation (Fukuda et al., 1995) . The ability of the kinase to participate in contrasting cellular processes may be a function of transient versus sustained MAPK activity (Marshall, 1995) . Due to the capacity of MAPK to cooperate in both proliferation and dierentiation of neuronal cells, the kinase may also ®ll a bifunctional role during skeletal myogenesis. Support for this hypothesis comes from the work of Gredinger et al. (1998) . Using the mouse C2 myhoblast cell line, the authors reported that the levels of MAPK activity are low in the proliferating myoblast but increase during the transition to mature myocyte, suggesting the kinase may be important for dierentiation. Furthermore, elevated MAPK activity, imparted by expression of Raf CAAX or constitutively active MEK, appears to overcome the block to myogenesis imposed by high serum. Moreover, the authors ®nd that both of these upstream mediators of MAPK activity can enhance MyoD-directed gene transcription. On the other hand, an equally compelling case can be built for MAPK as an inhibitor of myogenic dierentiation. Dierentiation of C2C12 myoblasts is characterized by a reduction in p42 and p44 MAPK activity and, removal of MAPK activity promotes precocious dierentiation of these cells in the presence of serum mitogens (Bennett and Tonks, 1997) . A similar situation exists for L6A1 myoblasts, in that, MAPK is critical for proliferation but inhibitory to dierentiation (Coolican et al., 1997) . And, our results clearly demonstrate a dramatic repressive eect of elevated MAPK on myocyte formation. Indeed, avian myoblasts, similar to C2C12 myoblasts, contain low levels of active MAPK that fall below detection limits in mature myocytes, strongly arguing against MAPK as a positive eector of myogenesis. The disparity amongst these reports may be a re¯ection of the inherent dierences between the myogenic cell systems employed. We believe the use of primary avian myoblasts are more indicative of the in vivo situation and, therefore, represent a more appropriate model to address myogenic mechanisms. As such, our results favor an inhibitory role for MAPK during myogenesis, in agreement with the ®ndings of Bennett and Tonks (1997) and Coolican et al. (1997) .
Our contention that MAPK is inhibitory to myogenesis is further supported by the ®nding that endogenous levels of phosphorylated MAPK are low to undetectable in the dierentiated cultures. Taking this into consideration, it was not surprising that reinduction of the MAPK signal was not only inhibitory to dierentiation but also detrimental to existing ®bers. One of the most striking features of the myo®bers overexpressing the activated forms of Raf, was the loss of myosin heavy chain expression. The residual myo®bers contained a discontinuous pattern of MyHC immunostaining insinuating that the ®bers were no longer capable of sustaining expression of the contractile protein. Because the MRFs are intricately involved in the regulation of musclespeci®c gene transcription, it is possible that chronic Raf activity in the myocyte impedes their function, thereby, promoting ®ber degeneration. However, in work not shown, we have found no dierences in the ability of the MRFs to bind to DNA in gel mobility shift assays, analogous to previous reports demonstrating that Ras inhibition of myogenesis was independent of altered MRF activity (Kong et al., 1995) . This raises the possibility that myogenic repression occurs via modification of alternate muscle transcription factors, such as MEF2 or MLP. Recently, such a scenario was described for TGF-b-mediated repression of myogenesis (DeAngelis et al., 1998) . Muscle cells treated with the inhibitory growth factor failed to dierentiate due to their inability to translocate MEF2 to the nucleus. Because evidence exists indicating that TGF-b-like morphogens can activate the Raf/MEK/MAPK pathway (Xu et al., 1996) , it is tempting to hypothesize that Raf-directed inhibition of dierentiation and/or ®ber degeneration may be attributed to loss of MEF2 function.
One of the more intriguing results of this study was the ®nding that the levels of MAPK generated by Raf CAAX were not produced by MEK activation. While the Ras pathway has been shown to direct MAPK activation by multiple means, we are unaware of other mammalian cell systems that utilize a divergent Raf pathway to activate downstream MAPK. Because a membrane-targeting signal was added to the Raf protein placing it in proximity to Ras, it is possible that we are actually initiating signaling cascades that are more reminiscent of Ras-induced pathways. In contrast, Raf BXB, which does not encode for an exogenous farnesylation sequence, transmits through MEK and may be more characteristic of endogenous Raf pathways. However, it is likely that activation of the Raf CAAX pathway does require a functional kinase domain as expression of a kinase defective form of Raf CAAX does not inhibit the ability of MyoD to activate a muscle-speci®c reporter gene in C3H10T1/2 cells (Dorman and Johnson, unpublished results). The identity of the Raf CAAX signaling intermediates is unknown but, may involve induction of protein kinase C (PKC) or phosphatidylinositol 3-kinase (PI3K) (Ueda et al., 1996; Joneson and Bar-Sagi, 1997) . In COS cells, activation of MAPK by PKC occurs through a MEK-dependent mechanism (Ueda et al., 1996) . Assuming avian myoblasts behave in a similar fashion, the likelihood of PKC induction of downstream MAPK activity is improbable. A more suitable candidate would be PI3K mediated signaling through a MEK-independent mechanism, a pathway responsible for sustained MAPK activity in ®broblasts (Duckworth and Cantley, 1997) . However, others have demonstrated that removal of PI3 kinase activity with chemical inhibitors is a hindrance to myogenic dierentiation (Coolican et al., 1997; Kaliman et al., 1998) . Also, we have found that treating avian myoblasts with wortmannin, a PI3K inhibitor, blocks dierentiation indicating that this kinase is required for myocyte formation (data not shown). As such, it is likely that the downstream signaling intermediates leading from Raf CAAX to MAPK do not include either PI3K or PKC.
In summary, overexpression of activated Raf is inhibitory to avian myogenesis in vitro. The failure to form multinucleated myocytes is a result of elevated MAPK activity. Interestingly, induction of MAPK in response to Raf occurs through both MEK-dependent and -independent signaling intermediates. Future work leading to the identi®cation of the components of the novel MEK-independent pathway will provide unique insight into muscle-speci®c signaling cascades.
Materials and methods
Proviral cDNA construction
The replication-competent retrovirus system (RCAS) described by Petropoulos and Hughes (1991) was used to overexpress a panel of human raf cDNAs. Prior to insertion into the retroviral vector RCAS(BP)A (RCAS), each of the raf cDNA constructs was subcloned into a modi®ed version of pCS2+MT (Turner and Weintraub, 1994) . This shuttle vector contains an internal ribosomal entry site (IRES) immediately upstream of a multimerized myc-epitope tag. Each of the cDNAs was cloned in frame with the myc tag and the resulting coding sequence and IRES excised by Cla digestion. The Cla fragment was subcloned into RCAS(BP)A and orientation determined by restriction mapping. The raf cDNAs inserted into RCAS include Raf CAAX, a cDNA encoding for full-length human Raf with a membrane localization signal, Raf BXB, a cDNA encoding for the kinase domain of human Raf and Raf BXB301, a cDNA encoding for a kinase-defective version of Raf BXB (Bruder et al., 1992) . Both Raf CAAX and Raf BXB are constitutively active while Raf BXB301 represents a dominant inhibitory form of the kinase.
Culture and transfection
Embryonic day ten (ED10) myoblasts were isolated from the hindlimbs of SPAFAS chick embryos (Preston, Conn). Brie¯y, the limbs were removed and dissected free of bone and skin. The muscle tissue was minced and incubated in GM (Dulbecco's modi®ed Eagle media containing 10% fetal bovine serum, 2% chicken serum, 1% penicillin/streptomycin, 0.5% gentamycin) at 378C with intermittent shaking for 20 min. The dissociated cells were passaged through 0.7-micron mesh ®lters (Falcon), collected by centrifugation and seeded on gelatin-coated plates in GM. Twelve to eighteen hours post-plating, the myoblasts were transiently transfected with the RCAS cDNA constructs. The proviral DNA was introduced by calcium phosphate precipitate formation and osmotic shock (Kong et al., 1995) . For cells cultured in 60 mm plates (5610 4 ), 2 mg of the RCAS constructs was transfected while 100 mm plates of cells (2.5610 5 ) received 5 mg. Cells were cultured in GM for the duration of the experimental period with media changed every third day. Myogenic cultures established and maintained in this fashion contained no more than 10% contaminating ®broblasts as determined by immunostaining for the L4 myoblast antigen.
Western analysis
Plates of myoblasts were washed twice with ice-cold TBS (10 mM TRIS, pH 8.0, 150 mM NaCl) and lysed with 46SDS ± PAGE sample buer (200 mM TRIS, pH 6.8, 400 mM dithiothreitol, 8% SDS, 40% glycerol). The lysates were heated at 1008C for 5 min followed by brief sonication to shear the genomic DNA. Equal amounts of total cellular protein were separated through 10% polyacrylamide denaturing gels. Proteins were immobilized on nitrocellulose by semi-dry electrophoretic transfer. Blots were blocked with 5% nonfat dry milk in TBS-T (TBS plus 0.1% Tween 20) for 60 min at room temperature. For the detection of Raf proteins, blots were incubated for 60 min with a mouse monoclonal antibody directed against the myc epitope (9E10 ascites¯uid) diluted 1 : 5000 in blocking solution. For the immunodetection of MAPK proteins, blots were incubated with rabbit polyclonal antibodies speci®c for MAPK or phosphoMAPK according to the manufacturer directions (New England Biolabs). After extensive washing with TBS-T, blots were incubated with the appropriate peroxidase conjugated secondary antibody. Immunocomplexes were visualized by chemiluminescence and exposure to X-ray ®lm (ECL, Amersham).
Immuno¯uorescent staining
Plates of cells were washed with phosphate buered saline (PBS) and ®xed with 90% methanol/10% PBS for 10 min. Cells were rehydrated in PBS and non-speci®c binding sites blocked with 5% horse serum in PBS containing 0.1% Triton X-100. Myosin heavy chain expression was detected using MF20, a monoclonal antibody speci®c for sarcomeric myosin (1 : 3 dilution of hybridoma supernatant). Myogenic cells were identi®ed with the monoclonal antibody L4 (1 : 3 dilution of hybridoma supernatant). Cells actively incorporating bromodeoxyuridine (BrdU) were identi®ed using a monoclonal antibody raised against the thymidine analog (1 : 1000, Research Diagnostics). Raf proteins were localized using the 9E10 monoclonal antibody directed against the myc epitope tag (1 : 5000 dilution of ascites). In all instances, cells were incubated in the appropriate primary antibody for 1 h at room temperature. After exhaustive rinsing with PBS, the plates were incubated for 40 min at room temperature with uorescein (FITC) or Texas Red conjugated goat anti-mouse antibodies diluted 1 : 150 in PBS (Vector Labs). For dual immunostaining, chain-speci®c secondary antibodies were used at a dilution of 1 : 150 (Southern Biotechnologies). In addition, 4,6-diamidino-2-phenylindole (DAPI, 0.1 mg/ml) was used as a nuclear stain. Immuno¯uorescence was visualized with a Nikon TE-200 microscope equipped with epi¯uorescence. Representative ®elds were photographed using Kodak EliteChrome slide ®lm, digitized and printed using Adobe Photoshop. For the quanti®cation of BrdUlabeled nuclei, the total number of nuclei and the number of BrdU-positive nuclei were counted in ten random microscope ®elds. The labeling index was calculated as the number of BrdU-positive nuclei divided by the total number of nuclei. Statistical analysis was performed using the Student t-test.
Genomic DNA fragmentation analysis
For the analysis of apoptosis, genomic DNA was isolated from infected cultures as described previously (Hermann et al., 1994) . Brie¯y, 100 mm plates of myoblasts were transfected with RCAS, RCAS-Raf CAAX or RCAS-Raf BXB and cultured for 4 days in GM. Cell pellets (3610 6 ) were collected from the infected cultures and lysed with 50 ml of 50 mM TRIS, pH 8.0, 1% NP40, 20 mM EDTA. Following centrifugation at 1600 g, the supernatants were retained, brought to a ®nal concentration of 1% SDS and sequentially digested with 200 mg/ml RNase A for 2 h at 568C and 100 mg/ml proteinase K for 2 h at 378C. Addition of 1/2 volume 10 M ammonium acetate and 2 volumes of 100% ethanol precipitated the genomic DNA. The ®nal DNA pellets were resuspended in 25 ml of 10 mM TRIS, pH 8.0, 1 mM EDTA and electrophoresed through 1.5% agarose gels. DNA bands were visualized by ethidium bromide staining. As a second measure of apoptosis, myocytes transduced with RCAS, RCAS-Raf BXB and RCAS-Raf CAAX were ®xed with 4% paraformaldehyde. Apoptotic DNA was detected using the ApoAlert DNA Fragmentation kit (Clontech) according to the manufacturer's recommendations.
